Agios Pharmaceuticals AGIO
NASDAQ AGIO
$37.35 +0.71 (+1.94%)
As of: Oct 21, 2026 · 2:11 PM EDT

Agios Pharmaceuticals (AGIO) Share-based Compensation (IS) (2018 - 2021)

Updated

Agios Pharmaceuticals (AGIO) recorded Share-based Compensation (IS) of $12.15 million in Q3 2021, down 18.9% from $14.98 million a year earlier and down 18.4% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Share-based Compensation (IS) (2018 - 2021) Analysis & Trends

On a TTM basis, Agios Pharmaceuticals' Share-based Compensation (IS) came in at $56.86 million as of Sep 30, 2021, up 1.1% year-over-year.

  • The Q3 2021 figure is the lowest quarterly Share-based Compensation (IS) since Q3 2018.
  • On a year-over-year basis, Share-based Compensation (IS) has declined for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,133.19 Bn 1,101.77 Bn 19.71 Bn -
2 Johnson & Johnson 616.03 Bn 534.56 Bn 17.26 Bn -
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn -
4 Merck 366.82 Bn 321.20 Bn 12.21 Bn -
5 Novartis Ag 297.82 Bn 261.81 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn -
7 Amgen 235.89 Bn 191.29 Bn 7.24 Bn -
8 Gilead Sciences 190.64 Bn 164.84 Bn 6.22 Bn -
9 Pfizer 169.32 Bn 115.96 Bn 10.94 Bn -
10 Agios Pharmaceuticals 2.22 Bn -939.99 Mn 41.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 12.15 Mn
Jun 30, 2021 14.89 Mn
Mar 31, 2021 14.85 Mn
Sep 30, 2020 14.98 Mn
Jun 30, 2020 17.61 Mn
Mar 31, 2020 15.67 Mn
Sep 30, 2018 8.00 Mn
API Access

Agios Pharmaceuticals Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=AGIO&period=max&api_key=YOUR_API_KEY